Cns

Edit

ORYZON announces appointment of Rolando Gutierrez-Esteinou, M.D., as Chief Medical Officer for CNS (ASEBIO - Asociación Española de Bioempresas)

Public Technologies 12 Feb 2026

) Partners Based in New Jersey (USA), to lead ORYZON's CNS clinical development. [...] ... Disclaimer ... (noodl. 129455945) .

Edit

Oncotelic Therapeutics, Inc. and Sapu Bioscience Expand International IP Coverage for OT-101, Strengthening CNS and ...

Nasdaq Globe Newswire 12 Feb 2026

... across neurology, oncology, and central nervous system (CNS) drug delivery.

Edit

ORYZON Announces Appointment of Rolando Gutierrez-Esteinou, M.D., as Chief Medical Officer for CNS

Nasdaq Globe Newswire 12 Feb 2026

... in epigenetics, today announced the appointment of Rolando Gutierrez-Esteinou, M.D., as Chief Medical Officer, CNS Programs.

Edit

ORYZON announces appointment of Rolando Gutierrez-Esteinou, M.D., as Chief Medical Officer for CNS (Oryzon Genomics SA)

Public Technologies 12 Feb 2026

ORYZON announces appointment of Rolando Gutierrez-Esteinou, M.D., as Chief Medical Officer for CNS. Based in New Jersey (USA), to lead ORYZON's CNS clinical development ... Medical Officer, CNS Programs.

Edit

The Biofield & Your CNS (Central Nervous System) w/ Sabrina Wallace & Dorian Russell | ...

Rumble 11 Feb 2026

Click the Rumble article link to see the video ....

Edit

Unlocking CNS insights: Continuous CSF sampling in first-in-human Alzheimer’s trials (Fortrea Holdings Inc)

Public Technologies 11 Feb 2026

) CASE STUDY Unlocking CNS insights ... Early Phase Development, CNS Biomarkers, CSF Sampling, Alzheimer's Disease Introduction This case study [...].

Edit

Center for Research on Families, SPHHS and CNS Faculty Members, Join North Shore Food is Medicine Collaboration (University of Massachusetts Amherst)

Public Technologies 10 Feb 2026

). The text version of this document is not available ... Disclaimer ... (noodl. 129406991) .

Edit

UK-Based Vesalic Limited Emerges from Stealth with Landmark Discovery of Potential Non-CNS Driver of Motor ...

Hastings Tribune 09 Feb 2026

This groundbreaking discovery has revealed a ...

Edit

Securing the last mile of digital transformation: Why print quality and security still matter

Tahawultech 09 Feb 2026

Baiju Kakkattuchalil, Director Office Business Solutions at CNS, discusses digital transformation agendas and why every endpoint can be a potential vulnerability ... Here, the CNS–Fujifilm partnership provides a powerful bridge ... CNS ....

Edit

UK-Based Vesalic Limited Emerges from Stealth with Landmark Discovery of Potential Non-CNS Driver of Motor Neuron Diseases, including ALS, and Breakthrough Therapeutic and Diagnostic Opportunities

Pharmiweb 09 Feb 2026

This groundbreaking discovery has revealed a systemic metabolic dysfunction that creates a toxic exosome cargo in ALS patients, which is carried to the CNS, where it binds to and damages neurons ... Lack of therapeutic success with brain and CNS targets.

Edit

Vect-Horus Enters a CNS-Focused Research Collaboration with OliX Pharmaceuticals

Nasdaq Globe Newswire 03 Feb 2026

Material Transfer and Evaluation Agreement (MTEA) to initiate a collaboration focused on siRNA delivery for central nervous system (CNS) disorders ... .

Edit

CNS visits IIT Kanpur: Adm Tripathi urges start-ups to continue pushing boundaries

Hindustan Times 03 Feb 2026

....

Edit

Cognision Launches Cognision360™: A Uniﬁed Platform Transforming Neurobiomarker Acquisition, Processing, and Analysis in CNS Clinical Trials

PR Newswire 03 Feb 2026

A Uniﬁed Platform Transforming Neurobiomarker Acquisition, Processing, and Analysis in CNS Clinical Trials ... Fragmented Data, Complex Trials Multi-site CNS clinical trials have long struggled with operational complexity.

Edit

SEQSTER Announces Expanded Partnership with Praxis Precision Medicines to Accelerate Clinical Trials in CNS Disorders

The Galveston Daily News 02 Feb 2026

SAN DIEGO & BOSTON--(BUSINESS WIRE)--Feb 2, 2026-- ....

Edit

RWS Launches New CNS Rater Training Service to Strengthen Data Quality in Clinical Trials

Business Wire 02 Feb 2026

... improve data quality, consistency and reliability in central nervous system (CNS) clinical trials.

Podcasts:

Latest News for: cns

ORYZON announces appointment of Rolando Gutierrez-Esteinou, M.D., as Chief Medical Officer for CNS (ASEBIO - Asociación Española de Bioempresas)

Oncotelic Therapeutics, Inc. and Sapu Bioscience Expand International IP Coverage for OT-101, Strengthening CNS and ...

ORYZON Announces Appointment of Rolando Gutierrez-Esteinou, M.D., as Chief Medical Officer for CNS

ORYZON announces appointment of Rolando Gutierrez-Esteinou, M.D., as Chief Medical Officer for CNS (Oryzon Genomics SA)

The Biofield & Your CNS (Central Nervous System) w/ Sabrina Wallace & Dorian Russell | ...

Unlocking CNS insights: Continuous CSF sampling in first-in-human Alzheimer’s trials (Fortrea Holdings Inc)

Center for Research on Families, SPHHS and CNS Faculty Members, Join North Shore Food is Medicine Collaboration (University of Massachusetts Amherst)

UK-Based Vesalic Limited Emerges from Stealth with Landmark Discovery of Potential Non-CNS Driver of Motor ...

Securing the last mile of digital transformation: Why print quality and security still matter

UK-Based Vesalic Limited Emerges from Stealth with Landmark Discovery of Potential Non-CNS Driver of Motor Neuron Diseases, including ALS, and Breakthrough Therapeutic and Diagnostic Opportunities

Vect-Horus Enters a CNS-Focused Research Collaboration with OliX Pharmaceuticals

CNS visits IIT Kanpur: Adm Tripathi urges start-ups to continue pushing boundaries

Cognision Launches Cognision360™: A Uniﬁed Platform Transforming Neurobiomarker Acquisition, Processing, and Analysis in CNS Clinical Trials

SEQSTER Announces Expanded Partnership with Praxis Precision Medicines to Accelerate Clinical Trials in CNS Disorders

RWS Launches New CNS Rater Training Service to Strengthen Data Quality in Clinical Trials

Article Search

EXPLORE WN.com